With over 1 million people living with HIV, the US faces national challenges in HIV care delivery due to an inadequate HIV specialist workforce and the increasing role of non-communicable chronic diseases in driving morbidity and mortality in HIV-infected patients. Alternative HIV care delivery models, which include substantial roles for advanced practitioners and/or coordination between specialty and primary care settings in managing HIV-infected patients, may address these needs. We aimed to systematically review the evidence on patient-level HIV-specific and primary care health outcomes for HIV-infected adults receiving outpatient care across HIV care delivery models. We identified randomized trials and observational studies from bibliographic and other databases through March 2016. Eligible studies met pre-specified eligibility criteria including on care delivery models and patient-level health outcomes. We considered all available evidence, including non-experimental studies, and evaluated studies for risk of bias. We identified 3605 studies, of which 13 met eligibility criteria. Of the 13 eligible studies, the majority evaluated specialty-based care (9 studies). Across all studies and care delivery models, eligible studies primarily reported mortality and antiretroviral use, with specialty-based care associated with mortality reductions at the clinician and practice levels and with increased antiretroviral initiation or use at the clinician level but not the practice level. Limited and heterogeneous outcomes were reported for other patient-level HIV-specific outcomes (e.g., viral suppression) as well as for primary care health outcomes across all care delivery models. No studies addressed chronic care outcomes related to aging. Limited evidence was available across geographic settings and key populations. As re-design of care delivery in the US continues to evolve, better understanding of patient-level HIV-related and primary care health outcomes, especially across different staffing models and among different patient populations and geographic locations, is urgently needed to improve HIV disease management.
Methods
The protocol for conducting this systematic review was developed and registered with PROSPERO (Chang & Slutsky, 2012 ) (PROSPERO number CRD42013005096 at http://www.crd.york.ac.uk/prospero/). The review was conducted according to the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines (Table S1) (Moher, Liberati, Tetzlaff, Altman, & Group, 2009 ). Detailed information on our methodologic approach is in the supplementary content.
Care delivery model definitions
We considered four delivery models (Box 1) for HIV treatment and care in the US, based on current and historical practice patterns in both US and international settings (Auerbach et al., 2013 ; Institute of Medicine (IOM), 2011; World Health Organization (WHO), 2014). We defined specialty-based care as HIV care delivered by physicians who primarily care for HIV-infected patients, making no assumptions regarding degree (e.g., Medicinae Doctor (MD), Doctor of Osteopathy (DO)) or specialty (infectious diseases, internal medicine, family medicine). We assumed that they managed most of their patients' HIV, chronic disease, wellness, and acute care needs. We defined advanced practitioner-based care as nurse practitioners and physician assistants who primarily care for HIV-infected patients. Similar to specialty-based care, advanced practitioners provide comprehensive HIV and non-HIV care, with support from specialists as needed, thus expanding the workforce. Team-based care is the comprehensive, patientcentered management of HIV-infected patients by a multidisciplinary team, including HIV specialists, primary care clinicians, advanced practitioners, case managers, social workers, and others. Teams are co-located, as in Ryan White Part C-funded practices (Saag, 2009) . We defined shared care as care co-management by HIV specialists, primary care clinicians, and others, similar to team-based care. However, we assumed that different team members were located in different settings, with systems in place for communication and care coordination. While we considered each care delivery model distinctly, we acknowledge the fluid nature of care delivery models and their overlap in practice, as well as the challenge of assigning a single care delivery model definition to studies examining physician or practice experience. For the latter, we assumed studies examining greater physician experience or expertise reflected specialty-based care, unless it was reported explicitly that the sample population (i.e., the physicians) worked in a team-based or shared care setting. 
Results
Our literature search resulted in 3661 records screened, of which 3641 were identified from databases, 20 from manual searches, and 56 were duplicates. After initial screening, 233 studies met inclusion criteria, thus excluding 3372 studies; in a second round of review, we eliminated an additional 220 from further consideration. The most common exclusion criterion was lack of care delivery model studied or described (3164). Thirteen studies were fully evaluated ( Figure 1 ) (Aiken et al., 1993; Chu, Umanski, Blank, Grossberg, & Selwyn, 2010; Ding et al., 2008; Gardner et al., 2002; Irvine et al., 2015; Keitz, Box, Homan, Bartlett, & Oddone, 2001; Kitahata et al., 1996 Kitahata et al., , 2003 Laine et al., 1998; Landon et al., 2003 Landon et al., , 2005 Lê, Winter, Boyd, Ackerson, & Hurley, 1998; Young et al., 2014) .
Care delivery models
Of 13 included studies, 9 evaluated specialty-based care. Of these, 7 examined only specialty-based care at the clinician (Keitz et al., 2001; Kitahata et al., 1996 Kitahata et al., , 2003 Landon et al., 2003 Landon et al., , 2005 and/or practice levels (Gardner et al., 2002; Keitz et al., 2001; Laine et al., 1998; Landon et al., 2005) , while 2 focused on specialty-based care and either advanced practitioner care (Ding et al., 2008) or shared care (Chu et al., 2010) . One study each evaluated only advanced practitioner care (Aiken et al., 1993) , teambased care (Irvine et al., 2015) , and shared care (Young et al., 2014) , while another assessed both team-based and shared care (Lê et al., 1998) .
Study characteristics
Data came from each treatment era considered, although primarily the combination therapy (7 of 13 studies) (Ding et al., 2008; Keitz et al., 2001; Kitahata et al., 1996 Kitahata et al., , 2003 Laine et al., 1998; Landon et al., 2003; Lê et al., 1998) and potent combination therapy (also 7 of 13 studies) (Chu et al., 2010; Ding et al., 2008; Gardner et al., 2002; Keitz et al., 2001; Kitahata et al., 2003; Landon et al., 2003 Landon et al., , 2005 eras. All except one study (Keitz et al., 2001) were non-experimental. Only 4 of 13 studies were published in the last decade (Chu et al., 2010; Ding et al., 2008; Irvine et al., 2015; Young et al., 2014) .
We evaluated study site location in the context of HIV burden and urbanicity. Five studies included practices located in the Northeast region (Pennsylvania, New York) (Aiken et al., 1993; Chu et al., 2010; Gardner et al., 2002; Irvine et al., 2015; Laine et al., 1998) , three in the West (California, Washington) (Kitahata et al., 1996 (Kitahata et al., , 2003 Lê et al., 1998) , one in the Midwest (Illinois) (Young et al., 2014) and two in the South (Maryland, North Carolina) (Gardner et al., 2002; Keitz et al., 2001) (Figure 2 ). Three were nationally representative (Ding et al., 2008; Landon et al., 2003 Landon et al., , 2005 , although only regional-level outcomes were reported. Of nine studies explicitly reporting specific study site location, six were in urban metropolitan areas and three in metropolitan areas serving a wider catchment area. One study, which included incarcerated individuals, reported on subjects from correctional facilities across the state of Illinois, although specific study sites or catchment areas were not reported (Young et al., 2014) .
Patient characteristics
Sample size ranged from 87 (Aiken et al., 1993) to 5247 patients (Lê et al., 1998 ) (median 871, interquartile range 2475 subjects). While one study included only females (Gardner et al., 2002) , the majority in the remaining studies were male (range 57% (Chu et al., 2010 ) -100% (Kitahata et al., 1996 (Kitahata et al., , 2003 ). African-Americans represented 30-78% of the study sample in six studies (Aiken et al., 1993; Chu et al., 2010; Ding et al., 2008; Irvine et al., 2015; Keitz et al., 2001; Landon et al., 2003) ; three studies reported <15% of the study sample as African-American (Kitahata et al., 1996 (Kitahata et al., , 2003 Lê et al., 1998) . While Hispanics and Latinos represented 44% of patients in one study and 38% in another (Chu et al., 2010; Irvine et al., 2015) , this group did not exceed 15% in five other studies (Ding et al., 2008; Kitahata et al., 1996 Kitahata et al., , 2003 Landon et al., 2003; Lê et al., 1998) and was not represented in the remaining studies (Aiken et al., 1993; Gardner et al., 2002; Keitz et al., 2001; Laine et al., 1998; Landon et al., 2005) . Two studies did not report race and ethnicity (Laine et al., 1998; Young et al., 2014) . Key populations included men who have sex with men (7 of 13 studies) (Chu et al., 2010; Ding et al., 2008; Keitz et al., 2001; Kitahata et al., 1996 Kitahata et al., , 2003 Landon et al., 2003; Lê et al., 1998) , injection drug users (5 of 13 studies) (Chu et al., 2010; Ding et al., 2008; Gardner et al., 2002; Keitz et al., 2001; Lê et al., 1998) , and prison inmates (1 of 13 studies) (Young et al., 2014) .
Patient outcomes
We found limited evidence on patient health outcomes associated with different HIV care delivery models. Evidence from three studies indicated greater clinician and practice experience with HIV care was associated with reduced mortality (Kitahata et al., 1996 (Kitahata et al., , 2003 Laine et al., 1998) . Four studies reported on retention in care, showing increased retention among patients receiving care from more experienced HIV clinicians (Keitz et al., 2001; Kitahata et al., 2003; Landon et al., 2005) or when enrolled in a comprehensive care coordination program (Irvine et al., 2015) ; there was no statistically significant effect at the practice level. Eight studies reported findings related to initiation or use of ART (Chu et al., 2010; Ding et al., 2008; Gardner et al., 2002; Keitz et al., 2001; Kitahata et al., 1996 Kitahata et al., , 2003 Laine et al., 1998; Landon et al., 2003 Landon et al., , 2005 , with evidence of increased antiretroviral use with more experienced or specialist HIV clinicians (Chu et al., 2010; Gardner et al., 2002; Kitahata et al., 1996; Landon et al., 2003 Landon et al., , 2005 but no statistically significant findings for antiretroviral use among more experienced practices (Ding et al., 2008) . Two studies indicated no statistically significant differences in referral for or use of mental health services (Aiken et al., 1993; Lê et al., 1998) , although patients who identified a regular HIV care clinician were less likely to receive care at facilities with a mental health professional or substance abuse counselors (Ding et al., 2008) . No chronic disease management outcomesincluding for cardiovascular disease, hypertension, and/or diabetes screening and/or treatmentwere reported. Hepatitis C screening did not differ by clinician type (HIV specialist vs. primary care) (Landon et al., 2005) ; however, tuberculosis screening occurred more frequently in primary care practices versus infectious disease practices (Keitz et al., 2001) as did influenza vaccination (Landon et al., 2005) . Only three studies (Ding et al., 2008; Keitz et al., 2001; Lê et al., 1998) and five studies (Aiken et al., 1993; Chu et al., 2010; Keitz et al., 2001; Kitahata et al., 2003; Lê et al., 1998) reported any patient-centeredness or resource utilization outcomes ( Figure S1 ).
Risk of bias
Across all eligible studies, selection bias was the primary identified bias, appearing in three of four study designs represented. Studies with a cross-sectional (Aiken et al., 1993; Ding et al., 2008; Gardner et al., 2002; Landon et al., 2005) , retrospective cohort (Chu et al., 2010; Kitahata et al., 1996 Kitahata et al., , 2003 Laine et al., 1998; Lê et al., 1998) , and randomized controlled trial (Keitz et al., 2001 ) study design generally received medium-quality ratings; two studies (Landon et al., 2003; Young et al., 2014) with an observational cohort study design received high-quality ratings (Table S7 ). We identified no bias across studies (e.g., publication bias), but found that the quality of the available data was limited by overall study design.
Discussion
We systematically reviewed and qualitatively synthesized evidence on patient health outcomes associated with different service delivery models for outpatient US HIV care. The evidence primarily addressed specialty-based care, supporting that better clinical outcomes are associated with increased clinician experience; limited data were available for other care models. Mainly mortality and clinical outcomes along the HIV care continuum were reported, but not chronic disease outcomes. Evidence was inconsistently available for key populations. Most studies were published over a decade ago and reflected study sites, and therefore patient populations, in Northeast and West metropolitan areas. Data quality was limited by overall study design.
Comparable questions on HIV service delivery have been posed for other complex, chronic diseases experiencing workforce shortages, fragmented care delivery, and escalating costs. For example, a larger, more equal role for advanced practitioners and team-based care across the cancer care continuum (IOM, 2013), and comprehensive, coordinated management including nursedirected care for diabetes mellitus type 2 (Kahn & Anderson, 2009 ), have been emphasized. As in HIV, limited US evidence exists.
HIV workforce challenges highlight a need for care delivery reform. Declines in the number of infectious diseases training programs and positions between 1994 and 2002 suggest difficulties in retaining infectious disease physicians (Knobler, Burroughs, Mahmoud, & Lemon, 2006) . This trend persists: in the July 2015 National Residency Matching Program, only half of infectious diseases programs filled their slots (Chandrasekar, 2015) . Similarly, projected shortfalls have been estimated in the supply of primary care physicians by 2020 (DHHS, 2013) . Logistical, legal, and policy challenges may limit ability of non-physician clinicians, particularly nurse practitioners, to manage HIV care. While the nurse practitioner workforce is projected to increase (DHHS, 2013), scope of practice varies. Only 20 US states authorize full practice authority (American Association of Nurse Practitioners, 2015) .
Little is known about non-HIV-specialist primary care clinicians' willingness to manage HIV. However, persons at risk for HIV, and therefore potential candidates for pre-exposure prophylaxis (PrEP), typically receive care from primary care clinicians, who may feel discomfort with prescribing PrEP and that it may not fall within their clinical purview (Hoffman et al., 2015; Krakower, Ware, Mitty, Maloney, & Mayer, 2014) . The literature also indicates educational (i.e., lack of knowledge or misperceptions) (Sison et al., 2013) and financial barriers (i.e., inadequate reimbursement) (Korthuis et al., 2011; White et al., 2015) to primary care physicians offering HIV testing and counseling. Many primary care physicians remain unaware of CDC's HIV testing recommendations (Arya et al., 2014) , and increased educational and outreach opportunities not only for HIV testing but also for HIV management may be required. Similarly, HIV specialists report feeling uncomfortable providing primary care to their HIV patients (Cheng, Engelage, Grogan, Currier, & Hoffman, 2014; Fultz et al., 2005) . For example, infectious disease and primary care clinicians practicing in infectious disease clinics are less comfortable providing care for HIV-related comorbiditieshyperlipidemia, diabetes, hypertension, and depressionthan general medicine physicians practicing in primary care settings (Fultz et al., 2005) . Mutual discomfort in providing care outside of their respective areas of expertise suggests the need for new models of HIV care that promote collaborative arrangements between HIV specialists and primary care physicians (Chu & Selwyn, 2011; Fultz et al., 2005) .
Finally, while federal legislation promotes team-based medicine, it is unclear how HIV care will be integrated into these reforms. HIV care received at Ryan White Part C-funded practices reflects such patient-centered, coordinated care (Saag, 2009 ), but the future of Ryan White funding remains unknown (Martin, Meehan, & Schackman, 2013) .
This study has several limitations. Although we included comprehensive search terms in our bibliographic search and supplemented with hand searching, few studies met selection criteria, and it is possible we missed some eligible studies. We also found inconsistent reporting of outcomes. Both restricted our ability to quantitatively synthesize the literature. While new care delivery models may be in use programmatically, they are absent from the literature and could benefit from rigorous implementation research. We included non-experimental studies, which may have bias compared to randomized controlled trials. There is possible bias due to a non-English language exclusion criterion. However, we do not believe this criterion materially affected our search or review findings, since the review was limited to a US context. Therefore, we would have expected that the vast majority of studies were published in English. We also excluded articles from non-US settings to limit cultural and health system factors potentially affecting the applicability of results to the US context. Finally, this review did not address intrapersonal outcomes, such as psychological resilience and social support, that are associated with improved wellbeing and reduced HIV-related risk behaviors among some key populations (Fang et al., 2015) , as well as stress, which is associated with poorer clinical outcomes (e.g., higher viral load) (Weinstein & Li, 2016) . As HIV care delivery models evolve, the role of advanced practitioners and social support in promoting resilience may warrant consideration (De Santis, Florom-Smith, Vermeesch, Barroso, & DeLeon, 2013) .
As HIV treatment management advances, HIV patients and the HIV workforce age, and national care delivery reforms are further implemented, adequate evidence to inform the future of HIV care delivery is imperative. We found that the limited and largely outdated data on patient health outcomes associated with HIV care delivery models are inadequate to inform future care delivery. A coordinated, detailed, and peerreviewed effort to better understand the HIV workforce and that addresses future workforce training and policies is crucial. Improved understanding of how different clinician roles and relationships affect patient outcomes and differences across target populations and geographic settings is critical to further improving health along the HIV care continuum.
